Prognostic factors in the hemolytic-uremic syndrome

Related Experiment Videos

M Uszycka-Karcz1, E Marczak, P Mierzewski

  • 1Pediatric Clinic of Nephrology, Gdańsk, Poland.

Child Nephrology and Urology
|January 1, 1988
PubMed

Insights

Hemolytic-uremic syndrome (HUS) in children has a 25.4% mortality rate, with infants most affected. Key fatal outcome predictors include severe GI symptoms, coma, and delayed dialysis.

Area of Science:

  • Pediatrics
  • Nephrology
  • Critical Care Medicine

Background:

  • Hemolytic-uremic syndrome (HUS) is a serious condition primarily affecting infants.
  • A significant mortality rate has been associated with HUS, necessitating identification of risk factors.

Purpose of the Study:

  • To identify risk factors associated with fatal outcomes in pediatric Hemolytic-uremic syndrome (HUS).
  • To analyze long-term sequelae in HUS survivors.

Main Methods:

  • Retrospective analysis of 142 children treated for HUS between 1972 and 1986.
  • Computerized analysis of clinical data to determine predictors of mortality.

Main Results:

  • The overall mortality rate for HUS was 25.4%, with infants comprising 73% of cases.
  • Identified risk factors for fatal outcomes included severe gastrointestinal symptoms, coma, convulsions, malignant hypertension, prolonged symptoms (>7 days), hyperkalemia (>7 mmol/l), acidosis (<15 mmol/l bicarbonate), delayed dialysis (>5 days), and long transport distances (>100 km).
  • The highest risk of death occurred within the first 3 weeks of onset.

Conclusions:

  • Early identification of risk factors is crucial for managing pediatric HUS.
  • Twelve of 106 survivors developed chronic renal failure, highlighting the need for long-term follow-up.

Related Concept Videos